These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34471711)

  • 41. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies.
    Nan H; Park C; Maeng S
    Biomed Res Int; 2020; 2020():2408402. PubMed ID: 33344633
    [No Abstract]   [Full Text] [Related]  

  • 42. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
    Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
    Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy.
    Viana GM; de Lima NO; Cavaleiro R; Alves E; Souza IC; Feio R; Leistner-Segal S; Schwartz I; Giugliani R; da Silva LC
    Genet Mol Biol; 2011 Jul; 34(3):410-5. PubMed ID: 21931511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
    Hendriksz CJ; Harmatz P; Beck M; Jones S; Wood T; Lachman R; Gravance CG; Orii T; Tomatsu S
    Mol Genet Metab; 2013; 110(1-2):54-64. PubMed ID: 23665161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucopolysacccharidoses: From understanding to treatment, a century of discoveries.
    Giugliani R
    Genet Mol Biol; 2012 Dec; 35(4 (suppl)):924-31. PubMed ID: 23411665
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Untargeted LC-HRMS metabolomics reveals candidate biomarkers for mucopolysaccharidoses.
    Torres CL; Scalco FB; de Oliveira MLC; Peake RWA; Garrett R
    Clin Chim Acta; 2023 Feb; 541():117250. PubMed ID: 36764508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis.
    Chuang CK; Lin SP; Chung SF
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):15-22. PubMed ID: 11310367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
    Chuang CK; Lin HY; Wang TJ; Tsai CC; Liu HL; Lin SP
    Orphanet J Rare Dis; 2014 Sep; 9():135. PubMed ID: 25178307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Enzymatic diagnosis of 47 cases with mucopolysaccharidosis].
    Zhang HW; Wang Y; Ye J; Qiu WJ; Han LS; Gao XL; Gu XF
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):276-80. PubMed ID: 19555566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Mucopolysaccharidosis: clinical features, diagnosis and management].
    Suarez-Guerrero JL; Gómez Higuera PJ; Arias Flórez JS; Contreras-García GA
    Rev Chil Pediatr; 2016; 87(4):295-304. PubMed ID: 26613630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enzyme replacement therapy interruption in mucopolysaccharidosis type IVA patients and its impact in different clinical outcomes.
    Politei J; Porras-Hurtado GL; Guelbert N; Fainboim A; Horovitz DDG; Satizábal JM
    JIMD Rep; 2021 Mar; 58(1):104-113. PubMed ID: 33728253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral treatment for mucopolysaccharidosis VI: Outcomes of the first phase IIa study with odiparcil.
    Guffon N; Chowdary P; Teles EL; Hughes D; Hennermann JB; Huot-Marchand P; Faudot-Vernier E; Lacombe O; Fiquet A; Richard MP; Abitbol JL; Tallandier M; Hendriksz CJ
    J Inherit Metab Dis; 2022 Mar; 45(2):340-352. PubMed ID: 34910312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey.
    Kilavuz S; Kor D; Bulut FD; Serbes M; Karagoz D; Altıntas DU; Bisgin A; Seydaoğlu G; Mungan HNO
    Arch Pediatr; 2022 Aug; 29(6):415-423. PubMed ID: 35705384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.
    Akyol MU; Alden TD; Amartino H; Ashworth J; Belani K; Berger KI; Borgo A; Braunlin E; Eto Y; Gold JI; Jester A; Jones SA; Karsli C; Mackenzie W; Marinho DR; McFadyen A; McGill J; Mitchell JJ; Muenzer J; Okuyama T; Orchard PJ; Stevens B; Thomas S; Walker R; Wynn R; Giugliani R; Harmatz P; Hendriksz C; Scarpa M; ;
    Orphanet J Rare Dis; 2019 Jun; 14(1):137. PubMed ID: 31196221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
    Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses.
    Baydakova G; Ilyushkina A; Gaffke L; Pierzynowska K; Bychkov I; Ługowska A; Wegrzyn G; Tylki-Szymanska A; Zakharova E
    Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32183018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical ocular manifestations of Taiwanese patients with mucopolysaccharidoses VI (Maroteaux-Lamy syndrome).
    Lin HY; Huang YH; Lei SY; Chen LJ; Lin SP
    Taiwan J Ophthalmol; 2019; 9(3):194-197. PubMed ID: 31572657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Cure for Sanfilippo Syndrome? A Summary of Current Therapeutic Approaches and their Promise.
    Pearse Y; Iacovino M
    Med Res Arch; 2020 Feb; 8(2):. PubMed ID: 32733997
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.